FNY Investment Advisers’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-7,144
Closed -$91K 958
2021
Q4
$91K Buy
+7,144
New +$79.1K 0.05% 216
2019
Q1
Sell
-200
Closed -$3K 1004
2018
Q4
$3K Sell
200
-1,067
-84% -$20.4K ﹤0.01% 568
2018
Q3
$18K Buy
+1,267
New +$18K ﹤0.01% 469

Other funds holding GRTS

FNY Investment Advisers's GRTS Position: Q1 2022 in Review

FNY Investment Advisers sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2022, closing a stake of 7,144 shares — an estimated $91K sold.

FNY Investment Advisers first reported a position in GRTS in Q3 2018 and held it in 3 quarters. The position peaked at $91K in Q4 2021. 117 funds tracked by Wall St. Rank hold GRTS as of Q1 2022.

  • FNY Investment Advisers reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 7,144 Gritstone bio, Inc. Common Stock shares in Q1 2022, an estimated $91K.
  • FNY Investment Advisers first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 3 quarters.
  • FNY Investment Advisers's Gritstone bio, Inc. Common Stock position peaked at $91K in Q4 2021.
  • 117 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2022.

Based on FNY Investment Advisers's 13F filing for Q1 2022, filed 25 Apr 2022.